› Forums › General Melanoma Community › KRAS nonBRAF melanoma mutation treatment options
- This topic has 6 replies, 2 voices, and was last updated 10 years ago by jjw2014.
- Post
-
- April 18, 2014 at 10:37 pm
My sister was informed today that she has a Negative BRAF gene mutation KRAS. SHe's not eligible for many clinical trials because her mutation is rare. Would like to know if any others share this same type of mutation and if so what treatment option they tried.
We are thinking of doing the IL2 first, then move to Yervoy, and hope that later on in the summer she will be eligible for a antipd1.
Can anyone give any advice on their cancer or a loved ones?
We need just a glimmer of hope..
PS her husband also has Melanoma stage 4 and so you can imagine how heartbreaking all this is with having 2 small children.
BTW she is 46, no other health issues, good shape, liver nodule is 3cm and the lungs are even detectable.
- Replies
-
-
- April 21, 2014 at 4:08 pm
I also am Braf negative – they refer to it as wild type meaning essentially none of the above.
Sloan Kettering is registering Braf negative wild type patients for a drug combo trial using trametinib and something that has not been FDA approved yet.
It's on their website under melanoma oncologists Paul Chapman and Michael Postow. I also saw something similar at another cancer center but am not sure where.
Hope this helps.
-
- April 21, 2014 at 4:08 pm
I also am Braf negative – they refer to it as wild type meaning essentially none of the above.
Sloan Kettering is registering Braf negative wild type patients for a drug combo trial using trametinib and something that has not been FDA approved yet.
It's on their website under melanoma oncologists Paul Chapman and Michael Postow. I also saw something similar at another cancer center but am not sure where.
Hope this helps.
-
- April 21, 2014 at 4:08 pm
I also am Braf negative – they refer to it as wild type meaning essentially none of the above.
Sloan Kettering is registering Braf negative wild type patients for a drug combo trial using trametinib and something that has not been FDA approved yet.
It's on their website under melanoma oncologists Paul Chapman and Michael Postow. I also saw something similar at another cancer center but am not sure where.
Hope this helps.
-
- You must be logged in to reply to this topic.